Early blood pressure support for children with sepsis
Part of Infections clinical trials.
This study tests whether giving a medicine to support blood pressure (inotrope) early, along with extra fluids, can help children with sepsis and shock. It may be an option for children whose shock is not improving after initial fluids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 28 days and under 18 years old.
- Your child has sepsis and still shows signs of shock after receiving at least 20 mL/kg of fluids in the last 4 hours.
- Your child has not already started a medicine to support blood pressure (an inotrope) before this study.
- Your child does not have a chronic heart, kidney, or liver disease, or a recent cardiac arrest.
- Your child's shock is likely caused by sepsis, not another condition like bleeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a medicine called norepinephrine early and adjusting the dose quickly can help people with sepsis who have very low blood pressure. It is for adults who are diagnosed within the last 3 hours and who have not already received this medicine.
This Phase 3 trial tests whether starting a medicine called norepinephrine early can improve outcomes for adults with sepsis (a serious body-wide response to infection) and low blood pressure. You might be considered if you’re very early in hospital care and meet specific blood pressure and lactate tests.
This study uses heart ultrasound (echocardiography) to help doctors decide how much fluid to give patients with sepsis, a serious blood infection. The goal is to improve how well the heart pumps and help patients recover better.
This study tests a personalized approach to giving fluids to patients with sepsis, a serious infection that can cause low blood pressure. The goal is to see if individualized fluid resuscitation improves outcomes compared to standard care.
This trial tests whether giving a second medicine called vasopressin early (along with norepinephrine) helps people with sepsis and low blood pressure better than waiting to use vasopressin only if norepinephrine doesn't work. It may improve blood pressure control and reduce the need for strong medicines.
This trial compares whether giving more liberal or more restricted IV fluids helps stabilize people with sepsis and low blood pressure. It may help your team choose a fluid strategy that better supports blood flow to your organs.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.